Gene polymorphism at position -308 of the tumor-necrosis-factor-α (TNF-α) in Multiple Sclerosis and its influence on the regulation of TNF-α production

Neuroscience Letters

Volumn 215, Issue 2, 1996, Pages 75-78

  Braun, N ^a   Michel, U ^b   Ernst, B P ^b   Metzner, R ^b   Bitsch, A ^b   Weber, F ^b   Rieckmann, P ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Adenosine; Guanine; Multiple Sclerosis; Tumor necrosis factor

Indexed keywords

ADENOSINE; GUANINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

EID: 0030572673     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)12920-7     Document Type: Article

References (20)

1. [1] Abraham, L.J. and Kroeger, K.M., Effect of the TNF-α -308 promoter polymorphism on transcription, Eur. Cytokine Netw., 7 (1996) 183.
2. [2] Brinkman, B.M., Giphart, M.J., Verhoef, A., Kaijzel, E.L., Naipal, A.M., Daha, M.R., Breedveld, F.C. and Verweij, C.L., Tumor necrosis factor α -308 gene variants in relation to major histocompatibility complex alleles and Felty's syndrome, Hum. Immunol., 41 (1994) 259-266.
3. [3] Brinkmann, B., Zuijdgeest, D., Kaijzel, E.L., Breedveld, F.C. and Verweij, C.L., Relevance of the tumor necrosis factor α (TNF-α) -308 promoter in TNF-α gene regulation, J. Inflammation, 46 (1996) 32-41.
4. [4] Cannella, B. and Raine, S., The adhesion molecule and cytokine profile of multiple sclerosis lesions, Ann. Neurol., 37 (1995) 424-435.
5. [5] Cox, A., Gonzalez, G., Wilson, A.G., Wilson, R.M., Ward, J.D., Artlett, C.M., Welsh, K. and Duff, G.W., Comparative analysis of the genetic association of HLA-DR3 and tumor necrosis factor-α with human IDDM, Diabetologie, 37 (1994) 500-503.
6. [6] Epplen, C., Dotzauer, B., Jäckel, S., Epplen, J.T., Przuntek, H. and Pöhlau, D., Multiple sclerosis (MS): relation of TNF-α promotor and HLA-DRB1 polymorphisms with constitutive TNF secretion, Eur. Cytokine Netw., 7 (1996) 255.
7. [7] He, B., Navikas, V., Lundahl, J., Soderstrom, M. and Hillert, J., Tumor necrosis factor α - 308 alleles in multiple sclerosis and optic neuritis, J. Neuroimmunol., 63 (1995) 143-147.
8. [8] McGuire, W., Hill, A.V., Allsopp, C.E., Greenwood, B.M. and Kwiatkowski, D., Variation of the TNF-α promoter region associated with susceptibility to cerebral malaria, Nature, 371 (1994) 508-510.
9. [9] Modaressi, S., Rupp, K., von Figura, K. and Peters, C., Structure of the human arylfatase B gene. Biol. Chem. Hoppe. Seyler, 374 (1993) 327-335.
10. [10] Olerup, O. and Hillert, J., HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation, Tissue Antigens, 38 (1991) 1-15.
11. [11] Pociot, F., D'Alfonso, S., Compasso, S., Scorza, R. and Richiardi, P.M., Functional analysis of a new polymorphism in the human TNF-α gene promoter, Scand. J. Immunol., (1995) 501-504.
12. [12] Rieckmann, P., Albrecht, M., Kitze, B., Weber, F., Tumani, H., Brooks, A., Lüer, W., Helwig, A. and Poser, S., Tumor necrosis factor α messenger RNA expression in patients with relapsing remitting multiple sclerosis associated with disease activity, Ann. Neural., 37 (1995) 82-88.
13. [13] Sharief, M.K., Phil, M. and Hentges, R., Association between the tumor-necrosis factor-α and disease progression in patients with multiple sclerosis, N. Engl. J. Med., 325 (1991) 467-472.
14. [14] Struber, F., Udalova, I.A., Book, M., Drutskaya, L.N., Kuprash, D.V., Turetskaya, R.L., Schade, F.U. and Nedospasov, S.A., -308 Tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter, J. Inflammation, 46 (1996) 42-50.
15. [15] Verjans, G.M., Brinkman, B.M., Van-Doornik, C.E., Kijlstra, A. and Verweij, C.L., Polymorphism of tumor necrosis factor α at position -308 in relation to ancylosing spondylitis, Clin. Exp. Immunol., 97 (1994) 45-47.
16. [16] Verjans, G.M., Messer, G., Weiss, E.H., van der Linden, S.M. and Kijlstra, A., Polymorphism of the tumor necrosis factor region in relation to disease, Rheum. Dis. Clin. North. Am., 18 (1992) 177-186.
17. [17] Weinshenker, B.G., Wingerchuk, D.M., Liu, Q., Schaid, D. and Sommer, S., Direct genomic sequencing to identify genetic variations associated with the course and outcome of multiple sclerosis, Neurology, 46 (1996) 336-337.
18. [18] Wilson, A.G., de Vries, N., Pociot, F., di Giovine, F.S., van der Putte, L.B.A. and Duff, G.W., An allelic polymorphism within the human tumor necrosis factor α promotor region is strongly associated with HLA A1, B8, and DR3 alleles, J. Exp. Med., 177 (1993) 557-560.
19. [19] Wilson, A.G., de-Vries, N., van-de-Putte, L.B. and Duff, G.W., A tumor necrosis factor-α polymorphism is not associated with rheumatic arthritis, Ann. Rheum. Dis., 54 (1995) 601-603.
20. [20] Zipp, F., Weber, F., Huber, S., Sotgiu, S., Czlonkowska, A., Holler, E., Albert, E., Weiss, E.H., Wekerle, H. and Hohlfeld, R., Genetic control of multiple sclerosis: increased production of lymphotoxin and TNF-α by HLA-DR2 + T cells, Ann. Neurol., 38 (1995) 702-704.